{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:01:39Z","timestamp":1785265299818,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T00:00:00Z","timestamp":1660089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010909","name":"Young Scientists Fund","doi-asserted-by":"publisher","award":["81700533"],"award-info":[{"award-number":["81700533"]}],"id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","award":["2017SF-116"],"award-info":[{"award-number":["2017SF-116"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","award":["2015JM8420"],"award-info":[{"award-number":["2015JM8420"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","award":["2015KTCL03-05"],"award-info":[{"award-number":["2015KTCL03-05"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]},{"name":"innovation and Development Foundation of Tangdu Hospital","award":["2017LCYJ003"],"award-info":[{"award-number":["2017LCYJ003"]}]},{"name":"innovation and Development Foundation of Tangdu Hospital","award":["2018JSYJ010"],"award-info":[{"award-number":["2018JSYJ010"]}]},{"name":"innovation and Development Foundation of Tangdu Hospital","award":["2019LCYJ005"],"award-info":[{"award-number":["2019LCYJ005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s10620-022-07660-z","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T09:02:44Z","timestamp":1660122164000},"page":"487-496","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Downregulation of miR-20b-5p Contributes to the Progression of Liver Fibrosis via the STAT3 Signaling Pathway In Vivo and In Vitro"],"prefix":"10.1007","volume":"68","author":[{"given":"Ling","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9484-1721","authenticated-orcid":false,"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jikai","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,10]]},"reference":[{"key":"7660_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","volume":"7","author":"SL Friedman","year":"2010","unstructured":"Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 2010;7:425\u2013436.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7660_CR2","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/nmat5024","volume":"16","author":"L Liu","year":"2017","unstructured":"Liu L, You Z, Yu H et al. Mechanotransduction-modulated fibrotic microniches reveal the contribution of angiogenesis in liver fibrosis. NAT MATER 2017;16:1252\u20131261.","journal-title":"NAT MATER"},{"key":"7660_CR3","doi-asserted-by":"publisher","first-page":"44545","DOI":"10.1038\/srep44545","volume":"7","author":"AB Ozturk","year":"2017","unstructured":"Ozturk AB, Storm G, Prakash J, Bansal R. Tyrosine kinase inhibitor BIBF1120 ameliorates inflammation, angiogenesis and fibrosis in CCl4-induced liver fibrogenesis mouse model. Sci Rep 2017;7:44545.","journal-title":"Sci Rep"},{"key":"7660_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2019.153055","volume":"63","author":"G Cao","year":"2019","unstructured":"Cao G, Zhu R, Jiang T, Tang D, Kwan HY, Su T. Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signaling. PHYTOMEDICINE 2019;63:153055.","journal-title":"PHYTOMEDICINE"},{"key":"7660_CR5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.dld.2014.12.017","volume":"47","author":"D Wang","year":"2015","unstructured":"Wang D, Yin J, Dong R et al. Inhibition of Janus kinase-2 signalling pathway ameliorates portal hypertensive syndrome in partial portal hypertensive and liver cirrhosis rats. Dig Liver Dis 2015;47:315\u2013323.","journal-title":"Dig Liver Dis"},{"key":"7660_CR6","doi-asserted-by":"publisher","first-page":"100652","DOI":"10.1039\/C6RA17459K","volume":"6","author":"LO Nunez","year":"2016","unstructured":"Nunez LO, Bohanon FJ, Wang X et al. STAT3 inhibition suppresses hepatic stellate cell fibrogenesis: HJC0123, a potential therapeutic agent for liver fibrosis. RSC Adv 2016;6:100652\u2013100663.","journal-title":"RSC Adv"},{"key":"7660_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.leukres.2018.04.014","volume":"70","author":"SG Papageorgiou","year":"2018","unstructured":"Papageorgiou SG, Kontos CK, Tsiakanikas P et al. Elevated miR-20b-5p expression in peripheral blood mononuclear cells: a novel, independent molecular biomarker of favorable prognosis in chronic lymphocytic leukemia. Leuk Res 2018;70:1\u20137.","journal-title":"Leuk Res"},{"key":"7660_CR8","first-page":"2806","volume":"40","author":"Y Luo","year":"2018","unstructured":"Luo Y, He J, Tao X et al. miR20b negatively regulates VEGF expression by targeting STAT3 in H22 hepatocellular carcinoma cells. Oncol Rep 2018;40:2806\u20132813.","journal-title":"Oncol Rep"},{"key":"7660_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.gene.2018.10.059","volume":"686","author":"B Tang","year":"2019","unstructured":"Tang B, Bao N, He G, Wang J. Long noncoding RNA HOTAIR regulates autophagy via the miR-20b-5p\/ATG7 axis in hepatic ischemia\/reperfusion injury. GENE 2019;686:56\u201362.","journal-title":"GENE"},{"key":"7660_CR10","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/hep.29690","volume":"67","author":"AK Singh","year":"2018","unstructured":"Singh AK, Rooge SB, Varshney A et al. Global microRNA expression profiling in the liver biopsies of hepatitis B virus-infected patients suggests specific microRNA signatures for viral persistence and hepatocellular injury. Hepatology 2018;67:1695\u20131709.","journal-title":"Hepatology"},{"key":"7660_CR11","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/jgh.13207","volume":"31","author":"D Wang","year":"2016","unstructured":"Wang D, Wang Q, Yin J et al. Combined administration of propranolol + AG490 offers better effects on portal hypertensive rats with cirrhosis. J Gastroenterol Hepatol 2016;31:1037\u20131044.","journal-title":"J Gastroenterol Hepatol"},{"key":"7660_CR12","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1136\/gutjnl-2016-313392","volume":"67","author":"DM Xiang","year":"2018","unstructured":"Xiang DM, Sun W, Ning BF et al. The HLF\/IL-6\/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis. GUT 2018;67:1704\u20131715.","journal-title":"GUT"},{"key":"7660_CR13","first-page":"19","volume":"2018","author":"CB Cummins","year":"2018","unstructured":"Cummins CB, Wang X, Nunez LO et al. Luteolin-mediated inhibition of hepatic stellate cell activation via suppression of the STAT3 pathway. Int J Mol Sci 2018;2018:19.","journal-title":"Int J Mol Sci"},{"key":"7660_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med 2019;65:37\u201355.","journal-title":"Mol Aspects Med"},{"key":"7660_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176173","volume":"12","author":"P Kagan","year":"2017","unstructured":"Kagan P, Sultan M, Tachlytski I, Safran M, Ben-Ari Z. Both MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activation. PLOS ONE 2017;12:e176173.","journal-title":"PLOS ONE"},{"key":"7660_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12876-017-0571-3","volume":"17","author":"B Duan","year":"2017","unstructured":"Duan B, Hu J, Zhang T et al. miRNA-338-3p\/CDK4 signaling pathway suppressed hepatic stellate cell activation and proliferation. BMC Gastroenterol 2017;17:12.","journal-title":"BMC Gastroenterol"},{"key":"7660_CR17","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1007\/s00204-018-2278-9","volume":"92","author":"L Tao","year":"2018","unstructured":"Tao L, Xue D, Shen D et al. MicroRNA-942 mediates hepatic stellate cell activation by regulating BAMBI expression in human liver fibrosis. Arch Toxicol 2018;92:2935\u20132946.","journal-title":"Arch Toxicol"},{"key":"7660_CR18","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.3892\/mmr.2015.4692","volume":"13","author":"Y Li","year":"2016","unstructured":"Li Y, Chen D, Jin L et al. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis. Mol Med Rep 2016;13:1895\u20131901.","journal-title":"Mol Med Rep"},{"key":"7660_CR19","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1089\/thy.2015.0578","volume":"26","author":"S Hong","year":"2016","unstructured":"Hong S, Yu S, Li J et al. MiR-20b displays tumor-suppressor functions in papillary thyroid carcinoma by regulating the MAPK\/ERK signaling pathway. Thyroid 2016;26:1733\u20131743.","journal-title":"Thyroid"},{"key":"7660_CR20","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1074\/jbc.M116.773085","volume":"292","author":"LY Tang","year":"2017","unstructured":"Tang LY, Heller M, Meng Z et al. Transforming growth factor-beta (TGF-beta) directly activates the JAK1-STAT3 axis to induce hepatic fibrosis in coordination with the SMAD pathway. J Biol Chem 2017;292:4302\u20134312.","journal-title":"J Biol Chem"},{"key":"7660_CR21","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1136\/gut.52.9.1347","volume":"52","author":"H Yoshiji","year":"2003","unstructured":"Yoshiji H, Kuriyama S, Yoshii J et al. Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis. Gut 2003;52:1347\u20131354.","journal-title":"Gut"},{"key":"7660_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jaut.2013.07.008","volume":"46","author":"YR Deng","year":"2013","unstructured":"Deng YR, Ma HD, Tsuneyama K et al. STAT3-mediated attenuation of CCl4-induced mouse liver fibrosis by the protein kinase inhibitor sorafenib. J Autoimmun 2013;46:25\u201334.","journal-title":"J Autoimmun"},{"key":"7660_CR23","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/cbdd.13160","volume":"91","author":"AM Sallam","year":"2018","unstructured":"Sallam AM, Esmat A, Abdel-Naim AB. Cucurbitacin-B attenuates CCl4-induced hepatic fibrosis in mice through inhibition of STAT-3. Chem Biol Drug Des 2018;91:933\u2013941.","journal-title":"Chem Biol Drug Des"},{"key":"7660_CR24","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3389\/fphys.2020.00617","volume":"11","author":"DM Tripathi","year":"2020","unstructured":"Tripathi DM, Hassan M, Siddiqui H et al. Cirrhotic endothelial progenitor cells enhance liver angiogenesis and fibrosis and aggravate portal hypertension in bile duct-ligated cirrhotic rats. Front Physiol 2020;11:617.","journal-title":"Front Physiol"},{"key":"7660_CR25","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/s41374-018-0127-3","volume":"98","author":"Z Wang","year":"2018","unstructured":"Wang Z, Li J, Xiao W, Long J, Zhang H. The STAT3 inhibitor S3I\u2013201 suppresses fibrogenesis and angiogenesis in liver fibrosis. Lab Invest 2018;98:1600\u20131613.","journal-title":"Lab Invest"},{"key":"7660_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118819","volume":"266","author":"Q Wang","year":"2021","unstructured":"Wang Q, Zhang F, Lei Y, Liu P, Liu C, Tao Y. microRNA-322\/424 promotes liver fibrosis by regulating angiogenesis through targeting CUL2\/HIF-1alpha pathway. Life Sci 2021;266:118819.","journal-title":"Life Sci"},{"key":"7660_CR27","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol 2017;14:397\u2013411.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"7660_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100316","volume":"3","author":"Y Iwakiri","year":"2021","unstructured":"Iwakiri Y, Trebicka J. Portal hypertension in cirrhosis: pathophysiological mechanisms and therapy. JHEP Rep 2021;3:100316.","journal-title":"JHEP Rep"},{"key":"7660_CR29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1478-3231.2010.02369.x","volume":"31","author":"S Coulon","year":"2011","unstructured":"Coulon S, Heindryckx F, Geerts A, Van Steenkiste C, Colle I, Van Vlierberghe H. Angiogenesis in chronic liver disease and its complications. LIVER INT 2011;31:146\u2013162.","journal-title":"LIVER INT"},{"key":"7660_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S1089-3261(19)30056-X","volume":"23","author":"S Saab","year":"2019","unstructured":"Saab S. Portal Hypertension. Clin Liver Dis 2019;23:13\u201314.","journal-title":"Clin Liver Dis"},{"key":"7660_CR31","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.jhep.2014.05.047","volume":"61","author":"Y Iwakiri","year":"2014","unstructured":"Iwakiri Y, Shah V, Rockey DC. Vascular pathobiology in chronic liver disease and cirrhosis - current status and future directions. J Hepatol 2014;61:912\u2013924.","journal-title":"J Hepatol"},{"key":"7660_CR32","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10456-016-9522-9","volume":"19","author":"JH Gao","year":"2016","unstructured":"Gao JH, Wen SL, Feng S et al. Celecoxib and octreotide synergistically ameliorate portal hypertension via inhibition of angiogenesis in cirrhotic rats. Angiogenesis 2016;19:501\u2013511.","journal-title":"Angiogenesis"},{"key":"7660_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22147662","volume":"22","author":"CK Pun","year":"2021","unstructured":"Pun CK, Huang HC, Chang CC et al. Glycyrrhizin attenuates portal hypertension and collateral shunting via inhibition of extrahepatic angiogenesis in cirrhotic rats. Int J Mol Sci 2021;22:1.","journal-title":"Int J Mol Sci"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07660-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-022-07660-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-022-07660-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T07:53:00Z","timestamp":1675842780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-022-07660-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,10]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["7660"],"URL":"https:\/\/doi.org\/10.1007\/s10620-022-07660-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,10]]},"assertion":[{"value":"4 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest with respect to this manuscript","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}